References

Gastric neuroendocrine neoplasms

10.1038/s41572-024-00508-y · 2024 · External reference

Unresolved reference

External reference

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

10.1111/jne.13306 · 2023 · External reference

10.1097/00000478-199610000-00001

10.1097/00000478-199610000-00001 · External reference

10.1016/j.cgh.2023.01.037

10.1016/j.cgh.2023.01.037 · External reference

Proton pump inhibitor use, hypergastrinemia, and gastric carcinoids—what is the relationship?

10.3390/ijms21020662 · 2020 · External reference

Metastatic multiple gastric neuroendocrine tumors with a long history of proton pump inhibitor use: A case report

10.28982/josam.1038661 · 2022 · External reference

10.3109/00365521.2011.627444

10.3109/00365521.2011.627444 · External reference

10.1080/00365521.2018.1450442

10.1080/00365521.2018.1450442 · External reference

10.1517/14740338.2016.1118050

10.1517/14740338.2016.1118050 · External reference

Classification of gastric neuroendocrine tumors and associations with survival

10.1002/jso.27876 · 2025 · External reference

10.1056/nejmra021405

10.1056/nejmra021405 · External reference

Diagnostic value of circulating chromogranin A for neuroendocrine tumors: a systematic review and meta-analysis

10.1371/journal.pone.0124884 · 2015 · External reference

The association between proton pump inhibitor use and gastroenteropancreatic neuroendocrine tumors: a systematic review

10.1007/s12029-025-01328-3 · 2025 · External reference

All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: a thorough update

10.1111/jne.13267 · 2023 · External reference

10.1056/nejm199011013231805

10.1056/nejm199011013231805 · External reference

Endoscopic diagnosis and management of type I neuroendocrine tumors

10.4253/wjge.v7.i4.346 · 2015 · External reference

Management of gastric neuroendocrine tumors: a review

10.1245/s10434-023-14712-9 · 2024 · External reference

Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors

10.3748/wjg.v20.i1.118 · 2014 · External reference

Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis

10.1111/his.14220 · 2020 · External reference

Association between long-term proton pump inhibitor use and low-risk gastric neuroendocrine tumors

10.1245/s10434-025-18430-2 · 2026 · External reference